Tragic revelations, made Friday by authorities in New Mexico, resolve many questions raised by the deaths of Gene Hackman and ...

In the final part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Jason C. Foster, CEO of Ori Biotech, ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

A Prescription Drug User Fee Act target date ... PRGN-2012 is an adenovirus vector-based gene therapy expected to induce immune responses against HPV 6 or 11 infected cells. Findings showed ...

AstraZeneca has entered into a definitive agreement to acquire EsoBiotec, a biotechnology company pioneering in vivo cell therapies that has demonstrated promising early clinical activity. The ...

Researchers in the current study designed a dual-function recombinant adeno-associated virus serotype 9 vector to deliver ... as a therapeutic alternative to prescription diet and liver transplant ...

Researchers in the current study designed a dual-function recombinant adeno-associated virus serotype 9 vector to deliver ... as a therapeutic alternative to prescription diet and liver transplant ...

Choose from Pharmacist Patient Prescription stock illustrations from iStock. Find high-quality royalty-free vector images that you won't find anywhere else. Video Back Videos home Signature collection ...

In the second part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Jason C. Foster, CEO of Ori Biotech, ...

Choose from Psychiatrist Prescription stock illustrations from iStock. Find high-quality royalty-free vector images that you won't find anywhere else. Video Back Videos home Signature collection ...

AstraZeneca to acquire EsoBiotec to advance cell therapy ambition Acquisition includes world-leading in vivo delivery platform with potential to transform cell therapy AstraZeneca has ...